↓ Skip to main content

A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)

Overview of attention for article published in Psychopharmacology, January 2004
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
114 Dimensions

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)
Published in
Psychopharmacology, January 2004
DOI 10.1007/s00213-003-1739-9
Pubmed ID
Authors

Magdalena Kwiatkowska, Linda A. Parker, Page Burton, Raphael Mechoulam

Abstract

The 5-HT3 antagonist, ondansetron (OND), and the cannabinoid, delta9-tetrahydrocannabinol (delta9-THC), have been shown to interfere with emesis; however, their relative and/or combined effectiveness in suppressing vomiting produced by the chemotherapeutic agent, cisplatin, is unknown.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 4%
Argentina 2 3%
United Kingdom 1 1%
France 1 1%
Canada 1 1%
Unknown 69 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 17%
Student > Ph. D. Student 12 16%
Student > Bachelor 12 16%
Other 7 9%
Student > Master 7 9%
Other 15 19%
Unknown 11 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 17 22%
Medicine and Dentistry 12 16%
Psychology 9 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 10%
Neuroscience 6 8%
Other 9 12%
Unknown 16 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2021.
All research outputs
#12,901,057
of 22,758,963 outputs
Outputs from Psychopharmacology
#3,867
of 5,343 outputs
Outputs of similar age
#110,373
of 133,654 outputs
Outputs of similar age from Psychopharmacology
#36
of 47 outputs
Altmetric has tracked 22,758,963 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,343 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 133,654 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.